146 related articles for article (PubMed ID: 12184439)
1. Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.
Lehuédé G; Toussirot E; Despaux J; Michel F; Wendling D
Joint Bone Spine; 2002 Jun; 69(4):406-8. PubMed ID: 12184439
[TBL] [Abstract][Full Text] [Related]
2. Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease?
David-Vaudey E; Jamard B; Hermant C; Cantagrel A
Clin Rheumatol; 2004 Aug; 23(4):376-8. PubMed ID: 15293107
[No Abstract] [Full Text] [Related]
3. "Yellow nail syndrome" and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Arimori S
Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis.
Matsukawa Y; Saito N; Nishinarita S; Horie T; Ryu J
Clin Rheumatol; 1998; 17(1):73-4. PubMed ID: 9586686
[No Abstract] [Full Text] [Related]
5. Yellow nails associated with gold therapy for rheumatoid arthritis.
Roest MA; Ratnavel R
Br J Dermatol; 2001 Nov; 145(5):855-6. PubMed ID: 11736925
[No Abstract] [Full Text] [Related]
6. [Yellow-nail syndrome from d-penicillamine].
Lubach D; Marghescu S
Hautarzt; 1979 Oct; 30(10):547-9. PubMed ID: 521278
[TBL] [Abstract][Full Text] [Related]
7. Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases.
Nakagomi D; Ikeda K; Hirotoshi K; Kobayashi Y; Suto A; Nakajima H
Rheumatol Int; 2013 Mar; 33(3):793-7. PubMed ID: 22090009
[TBL] [Abstract][Full Text] [Related]
8. Nail-changes induced by penicillamine.
Bjellerup M
Acta Derm Venereol; 1989; 69(4):339-41. PubMed ID: 2568058
[TBL] [Abstract][Full Text] [Related]
9. Yellow nail syndrome associated with penicillamine therapy.
Ilchyshyn A; Vickers CF
Acta Derm Venereol; 1983; 63(6):554-5. PubMed ID: 6198852
[TBL] [Abstract][Full Text] [Related]
10. D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis.
Ciompi ML; Marchetti G; Bazzichi L; Puccetti L; Agelli M
Rheumatol Int; 1995; 15(3):95-7. PubMed ID: 8588126
[TBL] [Abstract][Full Text] [Related]
11. Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis.
Amor B; Mery C; de Gery A
Arthritis Rheum; 1982 Jun; 25(6):698-703. PubMed ID: 7046758
[TBL] [Abstract][Full Text] [Related]
12. [Yellow nail syndrome associated with rheumatoid arthritis. Regression under chrysotherapy].
Launay D; Hebbar M; Louyot J; Hachulla E; Hatron PY; Devulder B
Rev Med Interne; 1997; 18(6):494-6. PubMed ID: 9247055
[No Abstract] [Full Text] [Related]
13. Thymoma associated with rheumatoid arthritis after D-penicillamine treatment.
Tani K; Matsunaga K; Katoh K; Kawai T; Ueda A; Kase M; Lie JT
Br J Rheumatol; 1998 Apr; 37(4):472-3. PubMed ID: 9619910
[No Abstract] [Full Text] [Related]
14. D-penicillamine-induced myositis in rheumatoid arthritis.
Chappel R; Willems J
Clin Rheumatol; 1996 Jan; 15(1):86-7. PubMed ID: 8929785
[TBL] [Abstract][Full Text] [Related]
15. Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases.
Yamamoto T; Yokozeki H
Rheumatol Int; 2007 Apr; 27(6):603-4. PubMed ID: 17103174
[No Abstract] [Full Text] [Related]
16. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
[TBL] [Abstract][Full Text] [Related]
17. [Myasthenia gravis caused by D-penicillamine].
Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
[No Abstract] [Full Text] [Related]
18. Penicillamine in the etiology of bullous pemphigoid.
Weller R; White MI
Ann Pharmacother; 1998 Dec; 32(12):1368. PubMed ID: 9876821
[No Abstract] [Full Text] [Related]
19. Yellow nail syndrome associated with rheumatoid arthritis, thiol-compound therapy and early gastric cancer.
Taki H; Tobe K
BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605706
[No Abstract] [Full Text] [Related]
20. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.
Mathieson PW; Peat DS; Short A; Watts RA
Nephrol Dial Transplant; 1996 May; 11(5):863-6. PubMed ID: 8671912
[No Abstract] [Full Text] [Related]
[Next] [New Search]